FDA Approves OTC 12-Hour Cold and Fever Medication
The FDA approved over-the-counter Mucinex 12hr Cold & Fever Multi-Symptom.
The FDA approved over-the-counter Mucinex 12hr Cold & Fever Multi-Symptom.
On World Lung Cancer Day, international organizations advocate for earlier detection and screening to reduce mortality from lung cancer.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
The American College of Allergy, Asthma, and Immunology (ACAAI) outlines essential steps for families and school staff to navigate seasonal allergy triggers and respiratory health.
The collaboration will focus on a point-of-care testing platform designed to detect tuberculosis from respiratory and blood samples.
Pressure control-volume guarantee (PCV-VG) ventilation improved intraoperative respiratory mechanics but did not significantly reduce postoperative pulmonary complications compared with conventional volume control ventilation in patients undergoing emergency abdominal surgery.
The Society of Thoracic Surgeons (STS) appointed Justine Varieur Turco as its CEO and executive director, effective August 31, 2026.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.